Please provide your email address to receive an email when new articles are posted on . Individually tailored immunosuppressive therapy may help preserve vision in at least one eye in children with ...

An investigational Janus kinase 1 (JAK1) preferential inhibitor reduced the risk of treatment failure among patients with active noninfectious uveitis, the phase II randomized HUMBOLDT trial showed.

Owing to the propensity for visual loss, immunosuppressive treatment in the form of systemic and/or local therapy is often required for the management of noninfective intermediate and posterior ...

An estimated five to ten percent of blindness worldwide is due to the rare inflammatory eye disease uveitis. Intermediate uveitis is often associated with a chronic course of the disease and the need ...

A 55-year-old man with a medical history of hypertension and benign prostatic hypertrophy presented with 10 days of blurred vision in the right eye without associated pain or redness. On initial ...

Vitreous cysts are rare structural entities that have been reported sporadically in the literature. Several associations have been described, including retinitis pigmentosa, Toxoplasmosis, trauma, ...

Ophthalmologist_TS_78024029 An injectable fluocinolone acetonide long-acting implant may be able to effectively control intraocular inflammation, as well as improve visual acuity, in patients with a ...

Expert Rev Ophthalmol. 2012;7(6):587-594. Multiple sclerosis (MS) is a neurodegenerative disease that causes demyelination of the CNS. MS can cause a wide variety of neuro-ophthalmic manifestations ...

Q. I’m 64 and have been diagnosed with uveitis in my right eye. What causes it, and what’s the best treatment? A. Uveitis is inflammation of one or more of the parts of the uvea, the layer of tissue ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...